159 related articles for article (PubMed ID: 36825823)
21. Synthetic magnetic resonance imaging for primary prostate cancer evaluation: Diagnostic potential of a non-contrast-enhanced bi-parametric approach enhanced with relaxometry measurements.
Arita Y; Akita H; Fujiwara H; Hashimoto M; Shigeta K; Kwee TC; Yoshida S; Kosaka T; Okuda S; Oya M; Jinzaki M
Eur J Radiol Open; 2022; 9():100403. PubMed ID: 35242886
[TBL] [Abstract][Full Text] [Related]
22. Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.
Hiremath A; Shiradkar R; Merisaari H; Prasanna P; Ettala O; Taimen P; Aronen HJ; Boström PJ; Jambor I; Madabhushi A
Eur Radiol; 2021 Jan; 31(1):379-391. PubMed ID: 32700021
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
24. Assessment of deep learning-based reconstruction on T2-weighted and diffusion-weighted prostate MRI image quality.
Lee KL; Kessler DA; Dezonie S; Chishaya W; Shepherd C; Carmo B; Graves MJ; Barrett T
Eur J Radiol; 2023 Sep; 166():111017. PubMed ID: 37541181
[TBL] [Abstract][Full Text] [Related]
25. An integrated nomogram combining deep learning, Prostate Imaging-Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study.
Hiremath A; Shiradkar R; Fu P; Mahran A; Rastinehad AR; Tewari A; Tirumani SH; Purysko A; Ponsky L; Madabhushi A
Lancet Digit Health; 2021 Jul; 3(7):e445-e454. PubMed ID: 34167765
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of Interpretable Machine Learning Models for Clinically Significant Prostate Cancer Diagnosis in Patients With Lesions of PI-RADS v2.1 Score ≥3.
Ruan M; Liu Y; Yao K; Wang K; Fan Y; Wu S; Wang X
J Magn Reson Imaging; 2024 Feb; ():. PubMed ID: 38363125
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
[TBL] [Abstract][Full Text] [Related]
28. Detecting Adverse Pathology of Prostate Cancer With a Deep Learning Approach Based on a 3D Swin-Transformer Model and Biparametric MRI: A Multicenter Retrospective Study.
Zhao L; Bao J; Wang X; Qiao X; Shen J; Zhang Y; Jin P; Ji Y; Zhang J; Su Y; Ji L; Li Z; Lu J; Hu C; Shen H; Tian J; Liu J
J Magn Reson Imaging; 2024 Jun; 59(6):2101-2112. PubMed ID: 37602942
[TBL] [Abstract][Full Text] [Related]
29. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
30. Predicting clinically significant prostate cancer with a deep learning approach: a multicentre retrospective study.
Zhao L; Bao J; Qiao X; Jin P; Ji Y; Li Z; Zhang J; Su Y; Ji L; Shen J; Zhang Y; Niu L; Xie W; Hu C; Shen H; Wang X; Liu J; Tian J
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):727-741. PubMed ID: 36409317
[TBL] [Abstract][Full Text] [Related]
31. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
[TBL] [Abstract][Full Text] [Related]
32. Avoiding Unnecessary Systematic Biopsy in Clinically Significant Prostate Cancer: Comparison Between MRI-Based Radiomics Model and PI-RADS Category.
Cheng X; Chen Y; Xu H; Ye L; Tong S; Li H; Zhang T; Tian S; Qi J; Zeng H; Yao J; Song B
J Magn Reson Imaging; 2023 Feb; 57(2):578-586. PubMed ID: 35852438
[TBL] [Abstract][Full Text] [Related]
33. Weakly Supervised MRI Slice-Level Deep Learning Classification of Prostate Cancer Approximates Full Voxel- and Slice-Level Annotation: Effect of Increasing Training Set Size.
Weißer C; Netzer N; Görtz M; Schütz V; Hielscher T; Schwab C; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
J Magn Reson Imaging; 2024 Apr; 59(4):1409-1422. PubMed ID: 37504495
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
36. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.
Taghipour M; Ziaei A; Alessandrino F; Hassanzadeh E; Harisinghani M; Vangel M; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2019 Apr; 44(4):1520-1527. PubMed ID: 30361870
[TBL] [Abstract][Full Text] [Related]
37. Direct Comparison of PI-RADS Version 2 and 2.1 in Transition Zone Lesions for Detection of Prostate Cancer: Preliminary Experience.
Byun J; Park KJ; Kim MH; Kim JK
J Magn Reson Imaging; 2020 Aug; 52(2):577-586. PubMed ID: 32045072
[TBL] [Abstract][Full Text] [Related]
38. Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer.
Montoya Perez I; Merisaari H; Jambor I; Ettala O; Taimen P; Knaapila J; Kekki H; Khan FL; Syrjälä E; Steiner A; Syvänen KT; Verho J; Seppänen M; Rannikko A; Riikonen J; Mirtti T; Lamminen T; Saunavaara J; Falagario U; Martini A; Pahikkala T; Pettersson K; Boström PJ; Aronen HJ
J Magn Reson Imaging; 2022 Feb; 55(2):465-477. PubMed ID: 34227169
[TBL] [Abstract][Full Text] [Related]
39. MRI-Based Breast Cancer Classification and Localization by Multiparametric Feature Extraction and Combination Using Deep Learning.
Cong C; Li X; Zhang C; Zhang J; Sun K; Liu L; Ambale-Venkatesh B; Chen X; Wang Y
J Magn Reson Imaging; 2024 Jan; 59(1):148-161. PubMed ID: 37013422
[TBL] [Abstract][Full Text] [Related]
40. Fully Automatic Deep Learning in Bi-institutional Prostate Magnetic Resonance Imaging: Effects of Cohort Size and Heterogeneity.
Netzer N; Weißer C; Schelb P; Wang X; Qin X; Görtz M; Schütz V; Radtke JP; Hielscher T; Schwab C; Stenzinger A; Kuder TA; Gnirs R; Hohenfellner M; Schlemmer HP; Maier-Hein KH; Bonekamp D
Invest Radiol; 2021 Dec; 56(12):799-808. PubMed ID: 34049336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
